Publication | Closed Access

Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy

Hematological MalignancyChronic Myeloid LeukemiaCell TherapyClinical Scale ExpansionMalignant Blood DisorderStem Cell TransplantationImmunologyHematologyAutoimmunityCell BiologyBlood TransplantationImmunotherapyMedicineCell TransplantationNatural Killer CellsHealthy Donors